Search research articles
Contact Us
Filters
Showing results (281-290 of 301) with videos related to
Page
of 31
Sort By:
Chemmedchem
|
March 19, 2016
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus
Valerio Mammoli, Alessandro Bonifazi, Diego Dal Ben, et al.
Journal of Medicinal Chemistry
|
April 2, 2016
Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity
Mu-Fa Zou, Thomas M Keck, Vivek Kumar, et al.
Journal of Medicinal Chemistry
|
July 24, 2015
High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice
Comfort A Boateng, Oluyomi M Bakare, Jia Zhan, et al.
European Journal of Medicinal Chemistry
|
September 24, 2016
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT<sub>1A</sub> receptor over α<sub>1</sub>-adrenoceptor and D<sub>2</sub>-like receptor subtypes
Fabio Del Bello, Alessandro Bonifazi, Mario Giannella, et al.
Science (New York, N.Y.)
|
June 25, 2011
A cell cycle phosphoproteome of the yeast centrosome
Jamie M Keck, Michele H Jones, Catherine C L Wong, et al.
Pharmaceutics
|
February 25, 2023
Advanced Skin Antisepsis: Application of UVA-Cleavable Hydroxyethyl Starch Nanocapsules for Improved Eradication of Hair Follicle-Associated Microorganisms
Loris Busch, Anna Maria Hanuschik, Yuri Avlasevich, et al.
JCO Precision Oncology
|
July 12, 2021
Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer
Swapnil Parmar, Jamie M Keck, Ben Kong, et al.
Molecular Cancer Research : MCR
|
June 18, 2026
Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities
Jamie M Keck, Limin Zhu, Jayne M Stommel, et al.
Journal of Medicinal Chemistry
|
December 17, 2016
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D<sub>3</sub> Receptor
Mayako Michino, Comfort A Boateng, Prashant Donthamsetti, et al.
Journal of Medicinal Chemistry
|
April 29, 2020
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor Agonist
Amy E Moritz, R Benjamin Free, Warren S Weiner, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 301) with videos related to
Sort By:
Page
of 31
Chemmedchem
|
March 19, 2016
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus
Valerio Mammoli, Alessandro Bonifazi, Diego Dal Ben, et al.
Journal of Medicinal Chemistry
|
April 2, 2016
Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity
Mu-Fa Zou, Thomas M Keck, Vivek Kumar, et al.
Journal of Medicinal Chemistry
|
July 24, 2015
High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice
Comfort A Boateng, Oluyomi M Bakare, Jia Zhan, et al.
European Journal of Medicinal Chemistry
|
September 24, 2016
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT<sub>1A</sub> receptor over α<sub>1</sub>-adrenoceptor and D<sub>2</sub>-like receptor subtypes
Fabio Del Bello, Alessandro Bonifazi, Mario Giannella, et al.
Science (New York, N.Y.)
|
June 25, 2011
A cell cycle phosphoproteome of the yeast centrosome
Jamie M Keck, Michele H Jones, Catherine C L Wong, et al.
Pharmaceutics
|
February 25, 2023
Advanced Skin Antisepsis: Application of UVA-Cleavable Hydroxyethyl Starch Nanocapsules for Improved Eradication of Hair Follicle-Associated Microorganisms
Loris Busch, Anna Maria Hanuschik, Yuri Avlasevich, et al.
JCO Precision Oncology
|
July 12, 2021
Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer
Swapnil Parmar, Jamie M Keck, Ben Kong, et al.
Molecular Cancer Research : MCR
|
June 18, 2026
Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities
Jamie M Keck, Limin Zhu, Jayne M Stommel, et al.
Journal of Medicinal Chemistry
|
December 17, 2016
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D<sub>3</sub> Receptor
Mayako Michino, Comfort A Boateng, Prashant Donthamsetti, et al.
Journal of Medicinal Chemistry
|
April 29, 2020
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor Agonist
Amy E Moritz, R Benjamin Free, Warren S Weiner, et al.
Page
of 31